Home LiteratureArticle Details
PMID: 15167892 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor.

The EMBO journal ·Vol. 23 ·No. 12 ·2004-06-16 ·Pages 2325-35

Stamos J, Lazarus RA, Yao X, Kirchhofer D, Wiesmann C

Abstract

The Met tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), play important roles in normal development and in tumor growth and metastasis. HGF-dependent signaling requires proteolysis from an inactive single-chain precursor into an active alpha/beta-heterodimer. We show that the serine protease-like HGF beta-chain alone binds Met, and report its crystal structure in complex with the Sema and PSI domain of the Met receptor. The Met Sema domain folds into a seven-bladed beta-propeller, where the bottom face of blades 2 and 3 binds to the HGF beta-chain 'active site region'. Mutation of HGF residues in the area that constitutes the active site region in related serine proteases significantly impairs HGF beta binding to Met. Key binding loops in this interface undergo conformational rearrangements upon maturation and explain the necessity of proteolytic cleavage for proper HGF signaling. A crystallographic dimer interface between two HGF beta-chains brings two HGF beta:Met complexes together, suggesting a possible mechanism of Met receptor dimerization and activation by HGF.

MeSH Terms
Amino Acid Sequence Base Sequence Crystallography, X-Ray DNA Primers Hepatocyte Growth Factor/chemistry,metabolism Models, Molecular Molecular Sequence Data Protein Binding Sequence Homology, Amino Acid Surface Plasmon Resonance
Chemicals
DNA Primers Hepatocyte Growth Factor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Stamos Jennifer
Department of Protein Engineering, Genentech Inc., South San Francisco, CA 94080, USA.
Lazarus Robert A
Yao Xiaoyi
Kirchhofer Daniel
Wiesmann Christian
References (39)
39 references, click to expand
  1. Domains in plexins: links to integrins and transcription factors.
    Trends Biochem Sci. 1999 Jul;24(7):261-3 PMID: 10390613
  2. Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain binding.
    J Biol Chem. 1999 Oct 15;274(42):29937-43 PMID: 10514476
  3. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    EMBO J. 2001 Oct 15;20(20):5543-55 PMID: 11597998
  4. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
    Science. 2002 Apr 5;296(5565):151-5 PMID: 11884718
  5. Scatter-factor and semaphorin receptors: cell signalling for invasive growth.
    Nat Rev Cancer. 2002 Apr;2(4):289-300 PMID: 12001990
  6. Serine protease mechanism and specificity.
    Chem Rev. 2002 Dec;102(12):4501-24 PMID: 12475199
  7. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    J Cell Biochem. 2003 Feb 1;88(2):408-17 PMID: 12520544
  8. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.
    Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):223-36 PMID: 12784998
  9. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
    Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11574-8 PMID: 1280830
  10. c-Met: structure, functions and potential for therapeutic inhibition.
    Cancer Metastasis Rev. 2003 Dec;22(4):309-25 PMID: 12884908
  11. Structure of the semaphorin-3A receptor binding module.
    Neuron. 2003 Aug 14;39(4):589-98 PMID: 12925274
  12. The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D.
    Nat Struct Biol. 2003 Oct;10(10):843-8 PMID: 12958590
  13. Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.
    EMBO J. 1992 Jul;11(7):2503-10 PMID: 1321034
  14. Expression and characterization of hepatocyte growth factor receptor-IgG fusion proteins. Effects of mutations in the potential proteolytic cleavage site on processing and ligand binding.
    J Biol Chem. 1992 Dec 25;267(36):26166-71 PMID: 1334493
  15. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Cancer. 2003 Oct 1;98(7):1386-93 PMID: 14508824
  16. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.
    Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12039-44 PMID: 14528000
  17. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Cancer Res. 2003 Nov 15;63(22):7926-35 PMID: 14633723
  18. Met, metastasis, motility and more.
    Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25 PMID: 14685170
  19. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  20. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.
    Science. 1992 Jan 17;255(5042):306-12 PMID: 1549776
  21. Identification of a competitive HGF antagonist encoded by an alternative transcript.
    Science. 1991 Nov 29;254(5036):1382-5 PMID: 1720571
  22. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.
    Cell. 1991 Nov 29;67(5):901-8 PMID: 1835669
  23. Improved methods for building protein models in electron density maps and the location of errors in these models.
    Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9 PMID: 2025413
  24. Molecular cloning and expression of human hepatocyte growth factor.
    Nature. 1989 Nov 23;342(6248):440-3 PMID: 2531289
  25. Processing of X-ray diffraction data collected in oscillation mode.
    Methods Enzymol. 1997;276:307-26 PMID: 27754618
  26. Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation.
    Biochemistry. 1970 Apr 28;9(9):1997-2009 PMID: 5442169
  27. Plexin: a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions.
    Neuron. 1995 Jun;14(6):1189-99 PMID: 7605632
  28. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Protein Sci. 1994 Dec;3(12):2378-94 PMID: 7756992
  29. Structural basis of substrate specificity in the serine proteases.
    Protein Sci. 1995 Mar;4(3):337-60 PMID: 7795518
  30. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.
    J Cell Biol. 1994 Dec;127(6 Pt 2):1783-7 PMID: 7806559
  31. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin.
    FEBS Lett. 1993 Aug 9;328(1-2):25-9 PMID: 8344430
  32. A novel putative receptor protein tyrosine kinase of the met family.
    Oncogene. 1993 May;8(5):1195-202 PMID: 8386824
  33. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6140-4 PMID: 8392188
  34. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.
    J Cell Biol. 1993 Oct;123(1):223-35 PMID: 8408200
  35. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity.
    J Biol Chem. 1996 May 31;271(22):13110-5 PMID: 8662798
  36. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.
    J Cell Sci. 1998 Jan;111 ( Pt 2):237-47 PMID: 9405310
  37. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.
    FEBS Lett. 1997 Dec 22;420(1):1-6 PMID: 9450538
  38. Mode of receptor binding and activation by plasminogen-related growth factors.
    FEBS Lett. 1998 Jun 5;429(1):1-3 PMID: 9657372
  39. Plexin A is a neuronal semaphorin receptor that controls axon guidance.
    Cell. 1998 Dec 23;95(7):903-16 PMID: 9875845
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2004-06-16
Epub
2004-00-27
Pages
2325-35
Language
English
Region
England
NLM ID
8208664
PMCID
PMC423285
Subset
IM
Grants
NCRR NIH HHS · P41 RR001646 · United States
NCRR NIH HHS · RR-01646 · United States
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]